On March 4, 2025, the 12th CBIC Cell Biology Industry Conference and the 3rd International Cell Therapy and Regenerative Medicine (Chengdu) Conference, along with the 4th International Functional Medicine Innovation Conference, were grandly held in Chengdu! Representatives from authoritative associations and industry pioneers gathered together, and the plenary session provided in-depth analysis of industry trends through thematic reports. The conference has established three core themes: "Diversification and Application of Cell Industry", "Clinical and Industrial Transformation of Stem Cells", and "Innovative Technologies and Applications in Functional Medicine". Focusing on technological breakthroughs, cooperation, and exchanges, the organizing committee invites you to review the first day of the conference together!
In the morning, heavyweight guests gathered at the opening ceremony, including Niu Song, General Manager of Fanghe Exhibition Group, Yan Mei, First level Researcher of Chengdu Health Commission, An Cong, President of Sichuan Hospital Association, Zhao Cong, President of Chengdu High tech Medical Association, and Wang Xidan, Vice President and Secretary General of Sichuan Health Association. The conference was chaired by Li Luoyu, Secretary General of Jinjiang District Medical Association in Chengdu.
The theme of the afternoon's "Cell Innovation Therapy and Application" includes Chen Lin, Chief Scientist and Vice President of Hangzhou Zhongying Biomedical Technology Co., Ltd., Kang Weijie, Chief Medical Officer of Beijing Danji Health Technology Co., Ltd./Danji Health Management Director, Fang Quan, Chief Medical Officer of Yingbairui (Hangzhou) Biopharmaceutical Co., Ltd., Li Zhi, General Manager of Beijing Enze Kangtai Biotechnology Co., Ltd., Liang Juanjuan, Vice President of Shoudao (Shanghai) Network Technology Co., Ltd., Wang Jianxun, Chief Scientist of Shenzhen Cell Valley Biopharmaceutical Co., Ltd., Wu Changyou, Chief Strategic Scientist of Kanglitai Biopharmaceutical (Qingdao) Co., Ltd., and other experts who shared with everyone the nourishing cell method, precision nutrition, spot universal NK cells, and clinical applications of stem cell extracellular vesicles. Digital transformation The research progress of NK/CAR-NK cell therapy, tumor neoantigen drug research and other heavyweight topics accelerate the clinical application process and help the industry upgrade and transform rapidly.
Two sub sessions respectively presented "Clinical and Industrial Transformation of Stem Cells" and "Core Applications of Innovative Technologies in Functional Medicine", with a large number of heavyweight experts and industry experts sharing their themes.
Liu Shaoxian, Chairman of Chengdu Kang'anmei Biotechnology Co., Ltd., Liu Shize, Assistant to the President of Shandong Umbilical Cord Blood Bank, Li Xiaojing, Product Director of Zhejiang LuMo Scientific Instrument Co., Ltd. and a Ph.D. in Biology from Fudan University, Wang Binzhi, Deputy General Manager of Harvard Cell Science and Technology Research Institute in the United States, and Liu Yonghong, Senior Director of Translational Medicine at Yinuo Micro Pharmaceutical Technology Co., Ltd. shared hot topics in the fields of IPSC personalized storage, umbilical cord blood empowerment for a healthy future, cell biomimetic culture technology, intelligent cell workstations, and engineered exosomes loaded with functional proteins, bringing more inspiration to industry innovation.
He Jian, Director of Peking Union Medical College Luoqi Functional Medicine Center, Wei Fang, General Manager of Bohou Health Technology Co., Ltd., and other experts shared with everyone the relationship between functional medicine and longevity, chronic food allergy testing, and home scenario based functional medicine testing NAD+、 Innovative application topics such as chronic disease management. Experts such as Li Hong, Medical Director of Chengdu Anticell Biotechnology Co., Ltd., and Kuang Gaobo, Head of CMC Department of Guangzhou Zhiyi Biotechnology Co., Ltd., showcased hot topics such as skin brain axis systemic regeneration, innovative live biopharmaceutical development, hormone replacement therapy for anti-aging, functional medicine oxygen era, sugar obesity reversal, metabolic syndrome, integrated medical thinking, and human symbiotic microorganisms.